Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which was led by two Boston-area investors. The size of the round is a testament to the explosive growth ...

Cleveland HeartLab spun out of Clinic research and was nurtured into the marketplace by Cleveland Clinic Innovations, the hospital's technology transfer arm. Having outgrown its space, it is moving ...

Cardiac inflammation biomarker test company Cleveland HeartLab has been tapped as the Ohio Venture Association‘s “venture of the year.” The last year has been an eventful one for the Cleveland-based ...

A Cleveland Clinic spinoff company formed in late 2009 as the newest entry in the field of cardiovascular technology is now poised for more growth. Cleveland HeartLab president and chief executive ...

Active-Investors.com is currently working on the research report for China Cord Blood Corporation (NYSE: CO), which also belongs to the Healthcare sector as the Company Quest Diagnostics. Do not miss ...

Cleveland HeartLab has agreed to be acquired by Quest Diagnostics, a Fortune 500 medical testing company based in New Jersey. The deal should help the Cleveland Clinic spinout company accelerate its ...

The company has now raised a total of $8m for its AI-powered heart scanning and reporting platform. Medtech startup HeartLab has raised $2 million in its latest seed round, taking its total funding to ...

After hitting several roadblocks in getting grants from the National Institutes of Health and the National Science Foundation, Robert Petrocelli and Dr. Jonathan Elion thought it was time to take ...

Medtech startup HeartLab has today announced $3.5m has been raised through a funding round led by Silicon Valley’s Founders Fund that will supercharge its entry into the US market early next year.